Nanobiotechnology and Nanomedicine Companies
(Links listed alphabetically)
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | All
Showing results 1 - 14 of 14 for companies starting with I:
iCeutica has developed the Encapsulated Organic Nanoparticles (EON™) Platform to produce consistent nano-sized drug particles.
The company is a leader in life science fluidics, microfluidics, and optics, offering a three-fold advantage to customers by bringing optofluidic paths to life with strategic partnerships, breakthrough solutions, and proven expertise.
The company's focus is on the rapidly emerging field of nanobiotechnology with an emphasis on the early detection and localization of cancer and other human diseases. Their technologies also hold the promise of providing image-guided therapy for the treatment of these diseases, as well as providing new methods for therapeutic intervention.
The company's RiboLace micro- and nanoparticle technology is embedded in two products: for better RNA-seq experiments and for better Ribosome Profiling experiments.
(German language site) The company is a Contract Research Organisation for the development and improvement of advanced cell culture systems for industrial drug screening applications, biomaterial testing and pharma-toxicological research.
A spin off founded to commercialize FDEC FET nano sensor technology invented at Arizona State University.The novel nano sensor technology is capable of exponential capacitive transduction for ultra high sensitivity molecular detection, coupled with exceptional selectivity.
Inanovate creates nano-scale surface structures through a unique and proprietary process capable of nano-meter precision in a time and cost effective way. Leveraging this unique platform and expertise, Inanovate is developing nano-structured biochip substrates to facilitate the next generation in biochip technology.
The company has active internal drug discovery programs focused on the identification of novel small molecule drugs for oncology, inflammation, HIV and diabetes.
The company is engaged in R&D and production of nanomaterials and nanomaterials production equipment. Production program covers mostly antibacterial products for healthcare (patches, bandages), hygiene (insoles), cleaning and food industry. The company also produces unique machines for polymerisation of nanolayers at textile materials 'INM Foulard' and exclusively distributes unique patented electrospinning devices 'MultiSpin' and electrospinning devices clima control units 'ClimaSpin'.
Offers different microfluidic platforms that precisely manipulate different combinations of fluids to obtain jets, emulsions, bubbles, drops and particles in the nano and micrometric range.
The company's lead product in development is Amorphous Nano-Hydroxyapaite Powder. Nano-structured hydroxyapatite has several advantages over hydroxyapatite of larger particle size in its use in bone tissue engineering due to its higher surface area and consequently higher reactivity, which offers better cellular response. In addition, nano-sized hydroxyapatite is useful as an effective surface modification agent for binding numerous biological molecules.
The foundation of the company's IVEC™ drug delivery platform is based on polymer micelle technology, spherical nanosized capsules formed by the assembly of block copolymers in water.
The company specializes in providing protein engineering to pharmaceutical and biotechnology companies for the discovery, identification and design of new peptide, polypeptide, protein and antibody compounds using their proprietary technology.
Develops scientific instrumentation and software for biomolecular and cellular bio applications including submicron analytical devices.